PharmaTher Holdings Ltd. (CSE:PHRM)

Canada flag Canada · Delayed Price · Currency is CAD
0.5000
-0.0400 (-7.41%)
Aug 8, 2025, 1:27 PM EDT
-7.41%
Market Cap45.51M
Revenue (ttm)n/a
Net Income (ttm)-1.48M
Shares Out91.02M
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume356,212
Average Volume192,522
Open0.5700
Previous Close0.5400
Day's Range0.4600 - 0.5700
52-Week Range0.1550 - 0.6700
Beta3.54
RSI55.84
Earnings DateSep 26, 2025

About Summit Materials

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company’s product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson’s disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia and procedural sedation. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2019
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PHRM
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.